SPONSOR
University of Sao Paulo General Hospital
Total Trials
10
Recruiting
10
Phases
Phase 4
Conditions studied: Pulmonary HypertensionPulmonary ThromboembolismsERASCardiac SurgeryCardiac Surgery-CABGDigital HealthDiabetes; Neuropathy, Polyneuropathy (Manifestation)Respiratory InsufficiencyPressure InjuryIntensive Care Medicine
University of Sao Paulo General Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Pulmonary Hypertension, Pulmonary Thromboembolisms, ERAS, Cardiac Surgery.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Sao Paulo General Hospital
How many clinical trials has University of Sao Paulo General Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by University of Sao Paulo General Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Pulmonary Hypertension, Pulmonary Thromboembolisms, ERAS. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Sao Paulo General Hospital research focus on?
University of Sao Paulo General Hospital clinical trials span Pulmonary Hypertension, Pulmonary Thromboembolisms, ERAS, Cardiac Surgery, Cardiac Surgery-CABG, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Sao Paulo General Hospital clinical trial?
To participate in a University of Sao Paulo General Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Sao Paulo General Hospital trials with current recruitment status updated daily.
Clinical Trials by University of Sao Paulo General Hospital
NCT07453017
Recruiting
Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
Pulmonary Hypertension
NCT06786819
Recruiting
Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
ERAS
NCT05639478
Recruiting
FOot CAre and Exercises ImplementatioN for People With Diabetes in Primary Care
Diabetes; Neuropathy, Polyneuropathy (Manifestation)
NCT06819943
Recruiting
Effectiveness of Platform-Based Lateralization Therapy in Reducing Interface Pressure Between The Patient And The Support Surface
Respiratory Insufficiency
NCT05907239
Recruiting
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
Temporomandibular Joint Disorders
NCT07280741 Phase 4
Recruiting
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators
Autoimmune Rheumatic Diseases
NCT07777341
Recruiting
Study Evaluating the Effects of Red Grape Juice Consumption on Metabolism in Men With Coronary Artery Disease
Coronary Arterial Disease (CAD)
NCT07713914 Phase 4
Recruiting
Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH)
NCT06882265
Recruiting
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
ILD
NCT06850792
Recruiting
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology